{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:31:46Z","timestamp":1794537106604,"version":"4.9.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To compare the diagnostic efficacy and safety of CT-guided percutaneous core needle biopsy (CNB) and fine-needle aspiration (FNA) for pancreatic lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and Material:<\/jats:title>\n                    <jats:p>A total of 176 patients with 176 pancreatic lesions who visited our hospital between January 2016 and March 2021 were retrospectively analyzed. They were divided into three groups: FNA group A (&lt;1.5 cm between the lesion and great vessels necessitating FNA), FNA group B, and CNB (the latter two with \u22651.5 cm between the lesion and great vessels necessitating FNA). The sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and postoperative. The statistical analysis was done using Statistical Package for the Social Sciences version 17.0.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>One hundred and seventy six patient\u2019s specimens all met the requirements. There were no statistically significant differences in sensitivity, specificity, positive predictive value, negative predictive value, and accuracy between the CNB group and FNA group B, (P &gt; 0.05). Thirteen samples submitted for genetic testing (5 in CNB group, 4 in each of the FNA groups A and B) all met the standards of next-generation sequencing gene detection. The main complications of these groups included abdominal pain, fever, and hyperamylasemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>CT-guided percutaneous FNA and CNB have similar diagnostic efficacy for pancreatic biopsy. Furthermore, FNA has a wide range of puncture indications and is very safe. Like CNB, the obtained tissue through FNA can be genetically tested to guide clinical treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_1290_22","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T12:01:22Z","timestamp":1693224082000},"page":"904-909","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Comparison of core needle biopsy and fine-needle aspiration methods in CT-guided percutaneous sampling of pancreatic tumors"],"prefix":"10.4103","volume":"19","author":[{"given":"Jingjing","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Interventional Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenjie","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongmin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,8,28]]},"reference":[{"key":"R1-20241021","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet"},{"key":"R2-20241021","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4103\/jcrt.JCRT_563_20","article-title":"The clinical efficacy of computed tomography-guided 125I particle implantation combined with arterial infusion chemotherapy in the treatment of pancreatic cancer","volume":"17","author":"Yang","year":"2021","journal-title":"J Cancer Res Ther"},{"key":"R3-20241021","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4103\/jcrt.JCRT_1663_20","article-title":"Chinese expert consensus of image-guided irreversible electroporation for pancreatic cancer","volume":"17","author":"Wei","year":"2021","journal-title":"J Cancer Res Ther"},{"key":"R4-20241021","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4103\/jcrt.JCRT_803_20","article-title":"Advantages of interstitial radioactive seed implantation for the treatment of Stage III pancreatic cancer","volume":"17","author":"Gai","year":"2021","journal-title":"J Cancer Res Ther"},{"key":"R5-20241021","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"R6-20241021","doi-asserted-by":"crossref","first-page":"831","DOI":"10.4103\/jcrt.JCRT_408_18","article-title":"High-intensity focused ultrasound ablation for advanced pancreatic cancer","volume":"15","author":"Zhu","year":"2019","journal-title":"J Cancer Res Ther"},{"key":"R7-20241021","doi-asserted-by":"crossref","first-page":"439","DOI":"10.6004\/jnccn.2021.0017","article-title":"Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Tempero","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"key":"R8-20241021","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.carj.2018.10.014","article-title":"Image-guided percutaneous biopsy for pancreatic lesions:10-year experience in a tertiary cancer center","volume":"70","author":"Stella","year":"2019","journal-title":"Can Assoc Radiol J"},{"key":"R9-20241021","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.3748\/wjg.v19.i15.2368","article-title":"Ultrasound-guided vs endoscopic ultrasound-guided fine-needle aspiration for pancreatic cancer diagnosis","volume":"19","author":"Matsuyama","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R10-20241021","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s00330-015-4003-x","article-title":"Ultrasound-guided percutaneous fine-needle aspiration of solid pancreatic neoplasms:10-year experience with more than 2,000 cases and a review of the literature","volume":"26","author":"D'Onofrio","year":"2016","journal-title":"Eur Radiol"},{"key":"R11-20241021","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.clinimag.2014.06.010","article-title":"Evaluation of percutaneous ultrasound-guided biopsies of solid mass lesions of the pancreas:A center's 10-year experience","volume":"39","author":"Yang","year":"2015","journal-title":"Clin Imaging"},{"key":"R12-20241021","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00004728-200209000-00014","article-title":"Large core biopsy of thepancreas under CT fluoroscopy control:Results and complications","volume":"26","author":"Zech","year":"2002","journal-title":"J Comput Assist Tomogr"},{"key":"R13-20241021","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/jcu.22362","article-title":"Percutaileous ultrasound-guided core needle biopsy of solid pancreatic massses:Results in 250 patients","volume":"44","author":"Kahriman","year":"2016","journal-title":"J Clin Ultrasound"},{"key":"R14-20241021","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jvir.2010.01.011","article-title":"Quality improvement guidelines for percutaneous needle biopsy","volume":"21","author":"Gupta","year":"2010","journal-title":"J Vasc Interv Radiol"},{"key":"R15-20241021","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2214\/AJR.05.0366","article-title":"Evaluation of imaging-guided core biopsy of pancreatic mass","volume":"187","author":"Paulsen","year":"2006","journal-title":"AJR Am Roentgenol"},{"key":"R16-20241021","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.3748\/wjg.v21.i12.3579","article-title":"Computed tomography-guided percutaneous core needle biopsy in pancreatic tumor diagnosis","volume":"21","author":"Tyng","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R17-20241021","first-page":"357","article-title":"Complications in percutaneous aspiration biopsy of thepancreas","volume":"58","author":"Putnik","year":"2001","journal-title":"Vojnosanit Pregl"},{"key":"R18-20241021","article-title":"Metastatic pancreatic cancer:ASCO guideline update","volume":"5","author":"Sohal","year":"2020","journal-title":"J Clin Oncol"},{"key":"R19-20241021","year":"2021","journal-title":"Pancreatic adenocarcinoma"},{"key":"R20-20241021","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1093\/annonc\/mdx343","article-title":"Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer:A multicenter, randomized phase IIb study","volume":"28","author":"Schultheis","year":"2017","journal-title":"Ann Oncol"},{"key":"R21-20241021","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer","volume":"381","author":"Golan","year":"2019","journal-title":"N Engl J Med"},{"key":"R22-20241021","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00280-015-2788-6","article-title":"Family history as a marker of platinum sensitivity in pancreatic adenocarcinoma","volume":"76","author":"Fogelman","year":"2015","journal-title":"Cancer Chemother Pharmacol"},{"key":"R23-20241021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.19.02105","article-title":"Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair-deficient cancer:Results from the phase 2 KEYNOTE-158 study","volume":"38","author":"Marabelle","year":"2020","journal-title":"J Clin Oncol"},{"key":"R24-20241021","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(19)30691-6","article-title":"Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours:Integrated analysis of three phase 1-2 trials","volume":"21","author":"Doebele","year":"2020","journal-title":"Lancet Oncol"},{"key":"R25-20241021","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4103\/jcrt.JCRT_755_18","article-title":"Circulating annexin A2 as a biomarker in patients with pancreatic cancer","volume":"16","author":"Karabulut","year":"2020","journal-title":"J Cancer Res Ther"},{"key":"R26-20241021","doi-asserted-by":"crossref","first-page":"202","DOI":"10.6004\/jnccn.2019.0014","article-title":"Pancreatic Adenocarcinoma. version 1.2019","volume":"17","author":"Tempero","year":"2019","journal-title":"J Narl Compr Canc Netw"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1290_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:40:06Z","timestamp":1787067606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1290_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1290_22","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"2022-06-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}